Growth hormone, skin and wound healing - Experimental studies in the rat

APMIS, Supplement

Volumn 105, Issue 72, 1997, Pages 5-54

  Jørgensen, Peter Holmberg ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; GLUCOSE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HYDROXYPROLINE; PLACEBO; PROLINE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HORMONE ACTION; NONHUMAN; NUTRITION; PRIORITY JOURNAL; RAT; SKIN; SKIN FIBROBLAST; SKIN GRAFT; SUBCUTANEOUS DRUG ADMINISTRATION; WOUND HEALING; ANIMAL; BIOMECHANICS; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; HUMAN; INJURY; METABOLISM; PHYSIOLOGY; REVIEW; WISTAR RAT;

ANIMALS; BIOMECHANICS; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROXYPROLINE; PROLINE; RATS; RATS, WISTAR; SKIN; WOUND HEALING;

EID: 0030630255     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.1997.tb05602.x     Document Type: Article

References (361)

1. Dott NM. An investigation into the function of the pituitary and thyroid glands. Part I. Technique of their experimental surgery and summary of results. Q J Exp Physiol 1922; XIII: 241-282.
2. Cushing H, Reford LL. Is the pituitary gland essential to maintenance of life? John Hopkins Hosp Bull 1909; 217: 105-107.
3. Crowe SJ, Cushing H, Romans J. Experimental hypophysectomy. John Hopkins Hosp Bull 1910; 21: 127-169.
4. Aschner B. Über die funktion der hypophyse. Pflug Arch Ges Physiol 1912; 146: 1-146.
5. Evans HM, Simpson ME, Li GH. The gigantism produced in normal rats by injection of the pituitary growth hormone. I.- Body growth and organ changes. Growth 1948; 12: 15-32.
6. Li GH, Simpson ME, Evans HM. The growth of hypophysectomized female rats following chronic treatment with pure pituitary growth hormone. II. Some chemical components of the musculature, liver and blood plasma. Growth 1949; 13: 171-174.
7. Freud J, Levie LH, Kroon DB. Observations on growth (chondrotrophic) hormone and localization of its point of attack. J Endocrinol 1939; 1: 56-64.
8. Simpson ME, Evans HM, Li CH. The growth of hypophysectomized female rats following chronic treatment with pure pituitary growth hormone. Growth 1949; 13: 151-170.
9. Evans HM, Uyei N, Bartz QR, Simpson ME. The purification of the anterior pituitary growth hormone by fractionation with ammonium sulfate. Endocrinology 1938; 22: 483-492.
10. Greenspan FS, Li GH, Simpson ME, Evans HM. Bioassay of hypophyseal growth hormone: The tibia test. Endocrinology 1949; 45: 455-463.
11. Li CH, Evans HM, Simpson ME. Isolation and properties of the anterior hypophyseal growth hormone. J Biol Chem 1945; 159: 353-366.
12. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 1958; 18: 901-903.
13. Goeddel DV, Heynecker HL, Hozumi T, Arentz P, Itakura K, Yansura DG, Ross MJ, Miozz G, Crea R, Seeburg P.H. . Direct expression E. Coli of a DNA sequence coding for human growth hormone. Nature 1979; 281: 544-548.
14. Jónsdóttir I, Ekre H-PT, Perlmann P. Identity of pituitary and bacterial human growth hormone as determined by monoclonal antibodies (comparative study of pituitary and bacteria derived human growth hormone by monoclonal antibodies). Mol Immunol 1983; 20: 871-876.
15. Hintz RL, Rosenfeld RG, Wilson DM, Bennett A, Finno J, McClellan B, Swift R. Biosynthetic methionyl human growth hormone is biologically active in adult man. Lancet 1982; 1: 1276-1279.
16. Dalboge H, Dahl HHM, Pedersen J, Hansen JW, Christensen T. A novel enzymatic method for production of authentic hGH from an E.coli produced hGH-precursor. Bio/Techn 1987; 5:
17. Christensen T, Hansen JW, Pedersen J, Dalboge H, Carlsen S, Jensen EB, Jørgensen KD, Dinesen B, Nilsson P, Sorensen HH, Thomsen J,Kappelgaard AM. Biosynthetic human growth hormone identical with authentic material. In: Delivery systems for peptide drugs, edited by Davis SS, Ilium L and Tomlinson E. New York, London: Plenum Press, Life Sciences vol. 125,1987: 305-315.
18. Christensen T, Hansen JJ, Sorensen HH, Thomsen J. RP-HPLC of biosynthetic and hypophyseal human growth hormone. HPLC Biotechn 1988;
19. Jørgensen KD, Monrad JD, Brondum L, Dinesen B. Pharmacokinetics of biosynthetic and pituitary human growth hormones in rats. Pharmacol Toxicol 1988; 63: 129-134.
20. Jørgensen KD. Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Demonstration of antinatriuretic/antidiuretic and barbital sleep effects of human growth hormone in rats. Acta Endocrinol (Copenh) 1987; 114: 124-131.
21. Jørgensen JOL, Flyvbjerg A, Dinesen J, Lund H, Alberti KOMM, Ørskov H, Christiansen JS. Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study. Acta Endocrinol (Copenh) 1987; 116: 381-386.
22. Flaim KE, Li JB, Jefferson LS. Protein turnover in rat skeletal muscle: effects of hypophysectomy and growth hormone. Am J Physiol 1978; 234: E38-E43.
23. Jefferson LS, Robertson JW,Tolman EL. Effects of hypophysectomy on protein and carbohydrate metabolism in the perfused rat liver. In: Growth and growth hormone, edited by Pecile A and Muller EE. Amsterdam: Excerpta Medica, 1972: 106-123.
24. Riggs TR, Walker LM. Growth hormone stimulation of amino acid transport into rat tissues in vivo. J Biol Chem 1960; 235: 3603-3607.
25. Ray RR, Asling CW,Walker DG, Simpson ME, Li CH, Evans HM. Growth and differentiation of the skeleton in thyroidectomized-hypophysectomized rats treated with thyroxin, growth hormone, and the combination. J Bone Joint Surg 1954; 36-A: 94-103.
26. Brandt T, Zeisel HJ, Hermanussen M. Growth response after administration of pharmacological doses of growth hormone in rats. Growth Dev Aging 1988; 52: 193-200.
27. Guler H-P, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factor 1 stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988; 85: 4889-4893.
28. McCusker RH, Campion DR. Effect of growth hormone-secreting tumors on body composition and feed intake in young female wistar-furth rats. J Anim Sci 1986; 63: 1126-1133.
29. Mathews LS, Hammer RE, Brinster RL, Palmiter RD. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 1988; 123: 433-437.
30. Bates PC, Holder AT. The anabolic actions of growth hormone and thyroxine on protein metabolism in Snell dwarf and normal mice. J Endocrinol 1988; 119: 31-41.
31. Manson JM, Smith RJ,Wilmore DW Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Ann Surg 1988; 208: 136-142.
32. Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 1982; 55: 973-982.
33. Ng SF, Storlien LH, Kraegen EW, Stuart MC, Chapman GE, Lazarus L. Effect of biosynthetic human growth hormone on insulin action in individual tissues in rat in vivo. Metabolism 1990; 39: 264-268.
34. Moller N, Jørgensen JOL, Alberti KGMM, Flyvbjerg A, Schmitz O. Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab 1990; 70: 1179-1186.
35. Jørgensen PH, Andreassen TT, Jørgensen KD. Growth hormone influences collagen deposition and mechanical strength of intact rat skin. A dose-response study. Acta Endocrinol (Copenh) 1989; 120: 767-772.
36. Snyder DK, Underwood LE, Clemmons DR. Persistent lipolytic effect of exogenous growth hormone during caloric restriction. Am J Med 1995; 98: 129-134.
37. Edén S. Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinology 1979; 105: 555-560.
38. Edén S. The secretory pattern of growth hormone. An experimental study in the rat. Acta Physiol Scand Suppl 1978; 1-54.
39. Jansson JO, Edén S, Isaksson O. Sexual dimorphism in the control of growth hormone secretion. Endocr Rev 1985; 6: 128-150.
40. Tannenbaum GS, Martin JB. Evidence for an endogen-ous ultradian rythm governing growth hormone secretion in the rat. Endocrinology 1976; 98: 562-570.
41. Clark RG, Carlsson LMS, Robinson ICAF. Growth hormone secretory profiles in conscious female rats. J Endocrinol 1987; 114: 399-407.
42. Clark RG, Chambers G, Lewin J, Robinson ICAF. Automated repetitive microsampling of blood: Growth hormone profiles in concious male rats. J Endocrinol 1986; 111: 27-35.
43. Even P, Danguir J, Nicolaidis S, Rougeot C, Dray F. Pulsatile secretion of growth hormone and insulin in relation to feeding in rats. Am J Physiol 1987; 253: R772-R778.
44. Laftman P, Holmström T, Kairento AL, Nilsson OS, Sigurdsson F, Strömberg L. No effect of growth hormone on recovery of load-protected bone. Acta Orthop Scand 1988; 59: 24-28.
45. Saunders A, Terry LC, Audet J, Brazeau P, Martin JB. Dynamic studies of growth hormone and prolactin secretion in the female rat. Neuroendocrinology 1976; 21: 193-203.
46. Reichlin S. Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology 1961; 69: 225-230.
47. Frohman LA, Bernardis LL. Growth hormone and insulin levels in weanling rats with ventromedial hypothalamic lesions. Endocrinology 1968; 82: 1125-1132.
48. Martin JB, Renaud LP, Brazeau P. Pulsatile growth hormone secretion: suppression by hypothalamic ventromedial lesions and by long-acting somatostatin. Science 1974; 186: 538-540.
49. Millard WJ, Romano TM, Simpkins JW. Growth hormone and thyrotropin secretory profiles and provocative testing in aged rats. Neurobiol Aging 1990; 11: 229-235.
50. Jansson J-O, Albertsson-Wikland K, Eden S, Thorngren K-G, Isaksson O. Circumstantial evidence for a role of the secretory pattern of growth hormone in control of body growth. Acta Endocrinol (Copenh) 1982; 99: 24-30.
51. Barnard R, Waters M. Serum and liver cytosolic growth-hormone-binding proteins are antigenically identical with liver membrane 'receptor' types 1 and 2. Biochem J1986; 237: 885-892.
52. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987; 330: 537-543.
53. Spencer SA, Hammonds RG, Henzel WJ, Rodriguez H,Waters MJ,Wood WI. Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization and sequence. J Biol Chem 1988; 263: 7862-7867.
54. Baumbach WR, Horner DL, Logan JS. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev 1989; 3: 1199-1205.
55. Daughaday WH, Hall K, Raben MS, Salmon WD,Van den Brande JL,Van Wyk JJ. Somatomedin: Proposed designation for sulphation factor. Nature 1972; 235: 107.
56. Daughaday WH, Philips LS, Herington AC. Somatomedin generation by perfused livers. Adv Metab Dis 1975; 8: 151-157.
57. Binoux M, Hossenlopp P, Lassarre C, Seurin D. Somatomedin production by rat liver in organ culture. I. Validity of the technique. Influence of the released material on cartilage sulphation. Effects of growth hormone and insulin. Acta Endocrinol (Copenh) 1980; 93: 73-82.
58. Schwander JC, Hauri C, Zapf J, Froesch ER. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 1983; 113: 297-305.
59. D'Ercole AJ, Stiles AD, Underwood LE.Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine me chanisms of action. Proc Natl Acad Sci USA 1984; 81: 935-939.
60. Waters MJ, Barnard RT, Lobie PE, Lim L, Hamlin G, Spencer SA, Hammonds RG, Leung DW,Wood WI. Growth hormone receptors - their structure, location and role. Acta Paediatr Scand Suppl 1990; 366: 60-72.
61. Gluckman PD, Breier BH, Sauerwein H. Regulation of the cell surface growth hormone receptor. Acta Paediatr Scand Suppl 1990; 366: 73-78.
62. Morikawa M, Nixon T, Green H. Growth hormone and the adipose conversion of 3T3 cells. Cell 1982; 29: 783-789.
63. Nixon T, Green H. Contribution of growth hormone to the adipogenic activity of serum. Endocrinology 1984; 114: 527-532.
64. Morikawa M, Green H, Lewis UJ. Activity of human growth hormone and related polypeptides on the adipose conversion of 3T3 cells. Mol Cell Biol 1984; 4: 228-231.
65. Zezulak KM, Green H. The generation of insulin-like growth factor I-sensitive cells by growth hormone. Science 1986; 233: 551-553.
66. Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 1986; 83: 9343-9347.
67. Orlowski CC, Chernausek CC. Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in the rat. Endocrinology 1988; 122: 44-49.
68. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987; 8: 426-438.
69. Schlechter NL, Russel SM, Greenberg S, Spencer EM, Nicoll CS. A direct growth effect of growth hormone in rat hindlimb shown by arterial infusion. Am J Physiol 1986; 250: E231-E235.
70. Green H, Morikawa M, NixonT, A dual effector theory of growth-hormone action. Differentiation 1985; 195-198.
71. Isaksson OGP, Jansson JO, Gause I AM. Growth hor-mone stimulates longitudinal bone growth directly. Science 1982; 216: 1237-1239.
72. Russell SM, Spencer M. Local injections of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats. Endocrinology 1985; 116: 2563-2567.
73. Nilsson A, Isgaard J, Lindahl A, Peterson L, Isaksson Q Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats. Calcif Tissue Int 1987; 40: 91-96.
74. Humbel RE. Insulin-like growth factors I and II. Eur J Biochem 1990; 190: 445-462.
75. Froesch ER, Zapf J. Insulin-like growth factors and insulin: comparative aspects. Diabetologia 1985; 28: 485-493.
76. VanWyk JJ. The somatomedins: Biological actions and physiologic control mechanisms. In: Hormonal proteins and peptides, edited by Li CH. London: Academic Press, Inc., 1984: 81-125.
77. Hizuka N,Takano K, Shizume K, Asakawa K, Miyakawa M,Tanaka I, Horikawa R. Insulin-like growth factor I stimulates growth in normal growing rats. Eur J Pharmacol 1986; 125: 143-146.
78. Daughaday WH. The historical evolution of concepts of the role of the insulin-like growth factor. In: The Insulin-like Growth Factor. Structure and Biological Functions, edited by Schofield PN. New York: Oxford University Press, 1992: 5-11.
79. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 1985; 47: 443-467.
80. McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA, Clemmons DR. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 1990; 144: 244-253.
81. Clemmons DR, Underwood LE. Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr 1991; 11: 393-412.
82. McCusker RH,Clemmons DR. The insulin-like growth factor binding proteins: structure and biological functions. In: The Insulin-like Growth Factors. Structure and Biological Functions, edited by Schofield PN. New York: Oxford University Press, 1992: 110-150.
83. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J, Waters M J. Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 1990; 126: 467-471.
84. Moses AC, Cohen KL, Johnsonbaugh R, Nissley SP. Contribution of human somatomedin activity to the serum growth requirement of human skin fibroblasts and chick embryo fibroblasts in culture. J Clin Endocrinol Metab 1978; 46: 937-946.
85. Clemmons DR, Underwood LE,VanWyk JJ. Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts. J Clin Invest 1981; 67: 10-19.
86. Clemmons DR, Van Wyk JJ. Somatomedin-C and pla-telet derived growth factor stimulate human fibroblast replication. J Cell Physiol 1981; 106: 361-367.
87. Clemmons DR. Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. J Clin Endocrinol Metab 1984; 58: 850-856.
88. Conover CA, Hintz RL, Rosenfeld RG. Comparative effects of somatomedin C and insulin on the metabolism and growth of cultured human fibroblasts. J Cell Phys 1985; 122: 133-141.
89. Clemmons DR, Shaw DS. Purification and biologic properties of fibroblast somatomedin. J Biol Chem 1986; 261: 10293-10298.
90. Cook JJ, Haynes KM,Werther GA. Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production. J Clin Invest 1988; 81: 206-212.
91. Hill DJ, Camacho-Hubner C, Rashid P, Strain AJ, Clemmons DR. Insulin-like growth factor (IGF)-binding protein release by human fetal fibroblasts: dependency on cell density and IGF peptides. J Endocrinol 1989; 122: 87-98.
92. Conover CA, Liu F, Powell D, Rosenfeld RG, Hintz RL. Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation. J Clin Invest 1989; 83: 852-859.
93. Martin JL, Baxter RC. Transforming growth factor-b stimulates production of insulin-like growth fractorbinding protein-3 by human skin fibroblasts. Endocrinology 1991; 128: 1425-1433.
94. Martin JL, Ballesteros M, Baxter RC. Insulin-like growth factor-I (IGF-I) and transforming growth factor-b1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 1992; 131: 1703-1710.
95. Ballard J, Baxter R, Binoux M, Clemmons D, Drop S, Hall K, Hintz R, Rechter M, Rutanen E, Schwander J. On the nomenclature of the IGF binding proteins [letter]. Acta Endocrinol (Copenh) 1989; 121: 751-752.
96. Jørgensen PH, Andreassen TT. A dose-response study of the effects of biosynthetic human growth hormone on formation and strength of granulation tissue. Endocrinology 1987; 121: 1637-1641.
97. Jørgensen PH, Andreassen TT. Influence of biosynthetic human growth hormone on biomechanical properties of rat skin incisional wounds. Acta Chir Scand 1988; 154: 623-626.
98. Jørgensen PH, Bang C, Andreassen TT. Mechanical properties of skin graft wounds. Br J Plast Surg 1993; 46: 565-569.
99. Jørgensen PH, Bang C, Andreassen TT, Flyvbjerg A, Ørskov H. Dose-response study of the effect of growth hormone on mechanical properties of skin graft wounds. J Surg Res 1995; 58: 295-301.
100. Jørgensen PH, Oxlund H. Growth hormone increases the biomechanical strength and collagen deposition rate during the early phase of skin wound healing. Wound Rep Reg 1996; 4: 40-47.
101. Schwabe AD. Anorexia Nervosa. Ann Intern Med 1981; 94: 371-381.
102. Thomas GB, Mercer JE, Karalis T, Rao A, Cummins JT, Clarke IJ. Effect of restricted feeding on the concentrations of growth hormone (GH), gonadotropins, and prolactin (PRL) in plasma, and on the amounts of messenger ribonucleic acid for GH, gonadotropin subunits, and PRL in the pituitary glands of adult ovariectomized ewes. Endocrinology 1990; 126: 1361-1367.
103. Maiter D, Maes M, Underwood LE, Fliesen T, Gerard G, Ketelslegers J-M. Early changes in serum concentrations of somatomedin-C induced by dietary protein deprivation in rats: contributions of growth hormone receptor and post-receptor defects. J Endocrinol 1988; 118: 113-120.
104. VandeHaar MJ, Moats-Staats BM, Davenport ML, Walker JL, Ketelslegers J-M, Sharma BK, Underwood LE. Reduced serum concentrations of insulin-like growth factor-I (IGF-I) in protein-restricted growing rats are accompanied by reduced IGF-I mRNA levels in liver and skeletal muscle. J Endocrinol 1991; 130: 305-312.
105. Mulumba N, Massa G, Ketelslegers J-M, Maes M. Ontogeny and nutritional regulation of the serum growth hormone-binding protein in the rat. Acta Endocrinol (Copenh) 1991; 125: 409-415.
106. Thissen J-P, Triest S, Moats-Staats BM, Underwood LE, Mauerhoff T, Maiter D, Ketelslegers J-M. Evidence that pretranslational and translational defects decrease serum insulin-like growth factor-I concentrations during dietary protein restriction. Endocrinology 1991; 129: 429-435.
107. Straus DS,Takemoto CD. Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and -II, IGF binding protein-2, and serum albumin gene expression in rat. Endocrinology 1990; 127: 1849-1860.
108. Thissen JP,Triest S, Underwood LE, Maes M, Ketelslegers JM. Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats. Endocrinology 1990; 126: 908-913.
109. Thissen JP, Underwood LE, Maiter D, Maes M, Clemmons DR, Ketelslegers JM. Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. Endocrinology 1991; 128: 885-890.
110. Goldstein S, Philips LS. Extraction and nutritional/ hormonal regulation of tissue insulin-like growth factor 1 activity. J Biol Chem 1991; 266: 14725-14731.
111. Maiter D, FliesenT, Underwood LE, Maes M, Gerard G, Davenport ML, Ketelslegers JM. Dietary protein restriction decreases insulin-like growth factor I independent of insulin and liver growth hormone binding. Endocrinology 1989; 124: 2604-2611.
112. Ooi GT, Orlowski CC, Brown AL, Becker RE, Unterman TG, Rechler MM. Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proleins-1 and -2. Mol Endocrinol 1990; 4: 321-328.
113. Murphy LJ, Seneviratne C, Moreira P, Reid RE. Enhanced expression of insulin-like growth faclor-binding protein-I in the fasted rat: The effects of insulin and growth hormone administration. Endocrinology 1991; 128: 689-696.
114. Prockop DJ, Kivirikko KI. Collagens: Molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995; 64: 403-434.
115. Kühn K. The classical collagens: Types I, II and III. In: Structure and function of collagen types, edited by Mayne R and Burgeson RE. San Diego: Academic Press Inc., 1987: 1-42.
116. Fessier JH,Fessler LI. Type v collagen. In: Structure and function of collagen types, edited by Mayne R and Burgeson RE. San Diego: Academic Press Inc., 1987: 81-104.
117. Nimni ME. Collagen: Structure, function, and metabolism in normal and fibrotic tissue. Semin Arthritis Rheum 1983; 13: 1-86.
118. Burgeson RE, Nimni ME. Collagen types. Molecular structure and tissue distribution. Clin Orthop 1992; 250-272.
119. Oxlund H, Jørgensen PH, Ørtoft G, Andreassen TT. Alterations in the cross-links of skin collagen of rats treated with biosynthetic growth hormone. Connect Tissue Res 1991; 26: 65-75.
120. Merkel JR, DiPaolo BR, Hallock GC, Rice DC. Type I and III collagen content of healing wounds in fetal and adult rats. Proc Soc Exp Biol Med 1988; 187: 493-497.
121. Clore JN, Cohen IK, Diegelmann RF. Quantitation of collagen types I and III during wound healing in rat skin. Proc Soc Exp Biol Med 1979; 161: 337-340.
122. Grant ME, Ayad S.The collagens of skin: structure and assembly. Biochem SocTrans 1988; 16: 663-666.
123. Bornstein P. Structurally distinct collagen types. Ann Rev Biochem 1980; 49: 957-1003.
124. Mays PK, Bishop JE, Laurent GJ. Age-related changes in the proportion of types I and III collagen. Mech Ageing Dev 1988; 45: 203-212.
125. van Winkle W The fibroblast in wound healing. Surg Gynecol Obstet 1967; 124: 369-386.
126. Fessier JH, Fessier LI. Biosynthesis of procollagen. Annu Rev Biochem 1978; 47: 129-162.
127. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. The biosynthesis of collagen and its disorders. Part I. N Eng J Med 1979; 301: 13-23.
128. Robins SP. Functional properties of collagen and elastin. Baillieres Clin Rheumatol 1988; 2: 1-36.
129. Manschet J. The mechanical properites of human skin in vivo (thesis). Dissertatiedrukkerij Wibro, Nijmegen. 1985: 1-136.
130. KriegT, Hein R, Hatamochi A, Aumailley M. Molecular and clinical aspects of connective tissue. Eur J Clin Invest 1988; 18: 105-123.
131. Siegel RC. Lysyl oxidase. In: International review of connective tissue research, edited by Hall DA and Jackson DS. New York: Academic Press, 1979: 73-118.
132. Dombi GW, Haut RC, Sullivan WG. Correlation of high-speed tensile strength with collagen content in control and lathyritic rat skin. J Surg Res 1993; 54: 21-28.
133. Seyer-Hansen M, AndreassenTT, Oxlund H, Jørgensen PH. The influence of aminoguanidine on borohy-dride reducible collagen cross-links and wound strength. Connect Tissue Res 1991; 26: 181-186.
134. Bailey AJ,Etherington DJ. Metabolism of collagen and elastin. In: Comprehensive Biochemistry, edited by Florkin M, Neuberger A and van Deenen LLM. Amsterdam: Elsevier, 1980: 299-460.
135. Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Annu Rev Biochem 1984; 53: 717-748.
136. Barnard K, Light ND, Sims TJ, Bailey AJ. Chemistry of the collagen cross-links. Origin and partial characterization of a putative mature cross-link of collagen. Biochem J 1987; 244: 303-309.
137. Ricard-Blum S, Ville G. Collagen cross-linking. Cell Mol Biol 1988; 34: 581-590.
138. Last JA, Armstrong LG, Reiser KM. Biosynthesis of collagen crosslinks. Int J Biochem 1990; 22: 559-564.
139. Reiser KM, McCormick RJ, Rucker RB. Enzymatic and nonenzymatic cross-linking of collagen and elastin. Faseb J1992; 6: 2439-2449.
140. Reiser KM. Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice. J Gerontol 1994; 49: B71-B79.
141. Yamauchi M,Woodley DT, Mechanic GL. Aging and cross-linking of skin collagen. Biochem Biophys Res Commun 1988; 152: 898-903.
142. Robins SP, Shimokomaki M, Bailey AJ. The chemistry of the collagen cross-links. Age-related changes in the reducible components of intact bovine collagen fibres. Biochem J1973; 131: 771-780.
143. Flandin F, Herbage D, Buffevant C, Bazin S. Evolution of structural and biomechanical properties of rat skin collagen during maturation. Cell Mol Biol 1981; 27: 677-685.
144. Flandin F, Buffevant C, Herbage D. Age-related changes in the biochemical and physicochemical properties of rat skin. Collagen synthesis and maturation and mechanical parameters (uniaxial tension). Cell Mol Biol 1986; 32: 565-571.
145. Bailey AJ, Robins SP, Balian G. Biological significance of the intermolecular crosslinks of collagen. Nature 1974; 251: 105-109.
146. Yamauchi M, London RE, Guenat C, Hashimoto F, Mechanic GL. Structure and formation of a stable histidine-based trifunctional cross-link in skin collagen. J Biol Chem 1987; 262: 11428-11434.
147. Adams E, Frank L. Metabolism of proline and the hydroxyprolines. Ann Rev Biochem 1980; 49: 1005-10061.
148. Stellen MR. Some aspects of the metabolism of hydroxyproline studied with the aid of isotopic nitrogen. J Biol Chem 1945; 181: 31-37.
149. Pelerkofsky B, Udenfriend S. Conversion of proline to collagen hydroxyproline in a cell-free system from chick embryo. J Biol Chem 1963; 238: 3966-3977.
150. Peterkofsky B, Udenfriend S. Enzymatic hydroxylation of proline in microsomal polypeptide leading lo formation of collagen. Proc Natl Acad Sci USA 1965; 53: 335-342.
151. Neuman RE, Logan MA. The determinalion of col-lagen and elastin in tissues. J Biol Chem 1950; 186: 549-556.
152. Oxlund H, Sims T, Light ND. Changes in mechanical properties, thermal stability, reducible cross-links and glucosyllysines in rat skin induced by corticosteroid treatment. Acta Endocrinol (Copenh) 1982; 101: 312-320.
153. Stoltz M, Furthmayr H,Timpl R. Increased lysine hydroxylation in rat bone and tendon collagen and localization of the additional residues. Biochim Biophys Acta 1973; 340: 461-468.
154. Laurent GJ. Rates of collagen synthesis in lung, skin and muscle obtained in vivo by a simplified method using 3HProline. Biochem J1982; 206: 535-544.
155. Cohen K, Moore CD, Diegelmann RE Onset and localization of collagen synthesis during wound healing in open rat skin wounds (40470). Proc Soc Exp Biol Med 1979; 160: 458-462.
156. Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987; 252(Cell Physiol.21): C1-C9.
157. Mays PK, McAnulty RJ, Campa JS, Laurent GJ. Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production. Biochem J1991; 276: 307-313.
158. Bienkowski RS. Intracellular degradation of newly synthesized collagen. In: Current trends in the study of intracellularprotein degradation. II, edited by Knecht E and Grisolia S. New York: Springer International, 1990: 423-443.
159. Wijn P. The alinear viscoelastic properties of human skin in vivo for small deformations (thesis). H. Th. Peters, Nijmegen. 1980: 1-325.
160. Reishner R, Balogh B, Menzel EJ. Two-dimensional elastic properties of human skin in terms of an incremental model at the in vivo configuration. Med Eng Phys 1995; 17: 304-313.
161. Kenedi RM, Gibson T,Daly CH. Bio-engineering studies of the human skin II. In: Biomechanics and related bioengineering topics, edited by Kenedi RM. Oxford: Pergamon Press, 1965: 147-158.
162. Haut RC.The effects of orientation and location on the strength of dorsal rat skin in high and low speed tensile failure experiments. J Biomech Eng 1989; 111: 136-140.
163. Fry P, Harkness MLR, Harkness RD. Mechanical properties of the collagenous framework of skin in rats of different ages. Am J Physiol 1964; 206: 1425-1429.
164. Millington PF, GibsonT, Evans JH,Barbenel JC. Structural and mechanical aspects of connective tissue. In: Advances in Biomedical Engineering, edited by Kenedi RM. New York: Academic Press Inc., 1971: 189-248.
165. Daly CH. Biomechanical properties of dermis. J Invest Dermatol 1982; 79: 17s-20s.
166. Craik JE,McNeil IRR. Histological studies of stressed skin. In: Biomechanics and related bioengineering topics, edited by Kenedi RM. Oxford: Pergamon Press, 1965: 159-164.
167. Vogel HG. Tensile strength, relaxation and mechanical recovery in rat skin as influenced by maturation and age. J Med 1976; 7: 177-188.
168. Vogel HG. Influence of maturation and age on mechanical and biochemical parameters of connective tissue of various organs in the rat. Connect Tissue Res 1978; 6: 161-166.
169. Levenson SM, Geever EF, Crowley LV, Gates JF, Berard CW, Rosen H. The healing of rat skin wounds. Ann Surg 1965; 161: 293-308.
170. Oxlund H, Andreassen TT. The roles of hyaluronic acid, collagen and elastin in the mechanical properties of connective tissues. JAnat 1980; 131: 611-620.
171. Oxlund H. Relationships between the biomechanical properties, composition and molecular structure of connective tissues. Connect Tissue Res 1986; 15: 65-72.
172. Vogel HG. Correlation between tensile strength and collagen content in rat skin. Effect of age and cortisol treatment. Connect Tissue Res 1974; 2: 177-182.
173. Manson JMcK, Wilmore DW. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery 1986; 100: 188-197.
174. Clemmons DR, Snyder DK, Williams R, Underwood LE. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J Clin Endocrinol Metab 1987; 64: 878-883.
175. Ziegler TR,Young LS, Manson JM, Wilmore DW Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Ann Surg 1988; 208: 6-16.
176. Jiang Z-M, He G-Z, Zhang S-Y, Wang X-R,Yang N-F, Zhu Y, Wilmore DW Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 1989; 210: 513-525.
177. Piccolboni D, deVincentiis L, Guerriere G, Belli A, Romano L, Zofra S, Maglione A, de Vincentiis E. Nutritional and hormonal effects of biosynthetic human growth hormone in surgical patients on total parenteral nutrition. Nutr 1991; 7: 177-184.
178. Gump FE, Schwartz MS, Prudden JF. Studies on growth hormone: VI dependence of anabolism on the level of intake. Am J Med Sci 1960; 239: 27-32.
179. Trivedi P, Hindmarsh P, Risteli J, Risteli L, Mowat AP, Brook CGD. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen. J Pediatr 1989; 114: 225-230.
180. Ward HC, Halliday D, Sim J W Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987; 206: 56-61.
181. Douglas RG, Humberstone DA, Haystead A, Shaw JHF. Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition. Br J Surg 1990; 77: 785-790.
182. Fryburg DA, Gelfand RA, Barrett EJ. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991; 260: E499-E504.
183. Palmer RM, Flint DJ, MacRae JC, Fairhurst FE, Bruce LA, Mackie SC, Lobley GE. Effects of growth hormone and an antiserum to rat growth hormone on serum IGF-I and muscle protein synthesis and accretion in the rat. J Endocrinol 1993; 139: 395-401.
184. Jasin HE, Fink CW, Wise W, Ziff M. Relationship between urinary hydroxyproline and growth. J Clin Invest 1962; 41: 1928-1933.
185. Aer J, Halme J, Kivirikko KI, Laitinen O. Action of growth hormone on the metabolism of collagen in the rat. Biochem Pharmacol 1968; 17: 1173-1180.
186. August GP, Hung W, Houck JC.The effects of growth hormone therapy on collagen metabolism in children. J Clin Endocrinol Metab 1974; 39: 1103-1109.
187. Ledet T,Vuust J. Arterial procollagen type I, type III, and fibronectin. Effects of diabetic serum, glucose, insulin, ketone, and growth hormone studied on rabbit aortic myomedial cell cultures. Diabetes 1980; 29: 964-970.
188. Pell JM, Bates PC. Collagen and non-collagen protein turnover in skeletal muscle of growth hormone-treated lamb. J Endocrinol 1987; 115: R1-R4.
189. Lindstedt G,Weijkum L, Lundberg PA. Serum procollagen-III as indicator of therapeutic effect in children treated for somatotropin deficiency. Clin Chem 1984; 30: 1879-1880.
190. Danne Th, Grüters A, L'Allemand D, Schuppan D, Hahn EG, Weber B. Rapid monitoring of growth hormone treatment by serum determination of type III procollagen related antigens. Eur J Pediatr 1987; 146(1): 98.
191. Tapanainen P, Risteli L, Knip M, Käär M-L, Risteli J. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy. J Clin Endocrinol Metab 1988; 67: 1244-1249.
192. Jensen LT, Jørgensen JOL, Risteli J, Christiansen JS, Lorenzen I. Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. Acta Endocrinol (Copenh) 1991; 124: 278-282.
193. Carey DE, Goldberg B, Ratzan SK, Rubin KR, Rowe DW Radioimmunoassay for type I procollagen in growth hormone deficient children before and during treatment with growth hormone. Pediatr Res 1985; 19: 8-11.
194. Aspenberg P, Hansson LI, Thorngren KG. Modification of bone formation rate by growth hormone, melanocyte-stimulating hormone, and cortisone in the normal rat. Acta Anat 1985; 121: 84-88.
195. Jørgensen PH, Bak B, Andreassen TT. Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone. Bone 1991; 12: 353-359.
196. Ørtoft G, Oxlund H, Jørgensen PH, Andreassen TT. Glucocorticoid treatment or food deprivation counteract the stimulating effect of growth hormone on rat cortical bone strength. Acta Paediatr Scand 1992; 81: 912-917.
197. Brüel A, Oxlund H. Biosynthetic growth hormone changes the collagen and elastin contents and biomechanical properties of the rat aorta. Acta Endocrinol Copenh 1991; 125: 49-57.
198. Brüel A, Oxlund H. Biosynthetic growth hormone increases the collagen deposition rate in rat aorta and heart. Eur J Endocrinol 1995; 132: 195-199.
199. Christensen H, Andreassen TT, Oxlund H. Increased mechanical strength of left colon in old rats treated with growth hormone. Gerontology 1992; 38: 245-251.
200. Martin JL, Baxter RC. Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: Immunological relationship to other human IGF-BPs. Endocrinology 1988; 123: 1907-1915.
201. De Mellow JSM, Baxter RC. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 1988; 156: 199-204.
202. Brunius U. Wound healing impairment from sutures. Acta Chir Scand [Suppl] 1968; 395: 1-26.
203. Clark RAF. Cutaneous wound repair. In: Physiology, Biochemistry, and Molecular Biology of the Skin, edited by Goldsmith LA. New York: Oxford University Press, 1991: 576-601.
204. Wokalek H. Cellular events in wound healing. CRC Crit Rev Biocompatib 1988; 4: 209-246.
205. Kanzler MH, Gorsulowsky DC, Swanson NA. Basic mechanisms in the healing cutaneous wound. J Dermatol SurgOncol 1986; 12: 1156-1164.
206. Simpson DM, Ross R. The neutrophilic leukocyte in wound repair. A study with antineutrophilic serum. J Clin Invest 1972; 51: 2009-2023.
207. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78: 71-100.
208. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988; 241: 708-712.
209. Steenfos H, Lossing C, Hansson H-A. Immunohistochemical demonstration of endogenous growth factors in wound healing. Wounds 1990; 2: 218-226.
210. Nagaoka I,Trapnell BC, Crystal RG. Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937. J Clin Invest 1990; 85: 448-455.
211. Hell EA, Cruickshank CND. The effect of injury upon the uptake of 3H-thymidine by guinea pig epidermis. Exp Cell Res 1963; 31: 128-139.
212. Krawczyk WS, Wilgram GF. Hemidesmosome and desmosome morphogenesis during epidermal wound healing. J Ultrastruct Res 1973; 45: 93-101.
213. Winter GD. Epidermal regeneration studies in the domestic pig. In: Epidermal wound healing, edited by Maibach HI and Rovee DT. Chicago: Year Book Medical Publishers, Inc., 1972: 71-112.
214. Gabbiani G, Chapponnier C, Hüttner I. Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during wound healing. J Cell Biol 1978; 76: 561-568.
215. Clark RAF, Lannigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79: 264-269.
216. Stenn KS, Madri JA, Roll FJ. Migrating epidermis produces AB2 collagen and requires continual collagen synthesis for movement. Nature 1979; 277: 229-232.
217. Welsh MP, Clark RAF. Synchronous expression of TGF-beta inducible proteins in the epidermis of reepithelializing porcine wounds. Clin Res 1989; 37: 236A.
218. Wikner NE, Persichitte KA, Baskin JB, Nielsen LD, Clark RAF. Transforming growth factor-β stimulates the expression of fibronectin by human keratinocytes. J Invest Dermatol 1988; 91: 207-212.
219. Toda K-I, Tuan T-L, Brown PJ, Grinnell F. Fibronectin receptors of human keratinocytes and their expression during cell culture. J Cell Biol 1987; 105: 3097-3104.
220. Remensnyder JP, Majno G. Oxygen gradients in healing wounds. Am J Pathol 1968; 52: 301-319.
221. Imre G. Studies of the mechanism of neovascularization. Role of lactic acid. Br J Ophthalmol 1964; 48: 75-82.
222. Folkmann J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-447.
223. Buckley-Sturrock A, Woodward SC, Senior RM, Griffin GL, Klagsbrun M, Davidson JM. Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol 1989; 138: 70-78.
224. SatoY, Rifkin DB. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 1988; 107: 1199-1205.
225. Buckley A, Davidson JM, Kamerath CD, Wolt TB, Woodward SC. Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci USA 1985; 82: 7340-7344.
226. Porras-Reyes BH, Blair HC, Jeffrey JJ, Mustoe TA. Collagenase production at the border of granulation tissue in a healing wound: macrophage and mesenchymal collagenase production in vivo. Connect Tissue Res 1991; 27: 63-71.
227. Ross R, Benditt EP. Wound healing and collagen formation. I. Sequential changes in components of guinea pig skin wounds observed in the electron microscope. J Biophys Biochem Cytol 1961; 11: 677-700.
228. Grierson I, Joseph J, Miller M, Day JE. Wound repair: the fibroblast and the inhibition of scar formation. Eye 1988; 2: 135-148.
229. McCarthy K, Henson PM. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a desarg. J Immunol 1979; 123: 2511-2517.
230. Zeitz M, Ruiz-Torres A, Merker H-J. Collagen metabolism in granulating wounds of rat skin. Arch Dermatol Res 1978; 263: 207-214.
231. Gay S,Viljanto J, Raekallio J, Penttinen R. Collagen types in early phases of wound healing in children. Acta Chir Scand 1978; 144: 205-211.
232. Doillon CJ, Dunn G, Bender E, Silver FH. Collagen fiber formation in repair tissue: Development of strength and toughness. Coll Relat Res 1985; 5: 481-492.
233. Scharffetter K, Kulozik M, Stolz W, Lankat-Buttgereit B, Hatamochi A, Söhnchen R, Krieg T. Localization of collagen al (I) gene expression during wound healing by in situ hybridization. J Invest Dermatol 1989; 93: 405-412.
234. Mäkelä JK,Vuorio E. Type I collagen messenger RNA levels in experimental granulation tissue and silicosis in rats. Med Biol 1986; 64: 15-22.
235. Diegelmann RF, Rothkopf LC, Cohen IK. Measurement of collagen biosynthesis during wound healing. J Surg Res 1975; 19: 239-243.
236. Horslev-Petersen K, Kim KY, Pedersen LR, Bentsen KD, Uldbjerg N, Oxlund H, Garbarsch C, Hahn EG, Schuppan D, Lorenzen I. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats. APMIS 1988; 96: 793-804.
237. McGee GS, Davidson JM, Buckley A, Sommer A, Woodward SC, Aquino AM, Barbour R, Demetriou AA. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 1988; 45: 145-153.
238. Haukipuro K, Melkko J, Risteli L, Kairaluoma M, Risteli J. Synthesis of type I collagen in healing wounds in humans. Ann Surg 1991; 213: 75-80.
239. Eisenmenger W, Nerlich A, Glück G. Die bedeutung des Kollagens bei der Wundalterbestimmung. Z Rechtsmed 1988; 100: 79-100.
240. Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH. Modulation of fibroblast functions by interleukin 1: Increased steady state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1α and β. J Cell Biol 1988; 106: 311-318.
241. Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into extracellular matrix. J Biol Chem 1986; 261: 4337-4340.
242. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-β. J Exp Med 1987; 165: 251-256.
243. Duncan MR, Berman B. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985; 162: 516-527.
244. Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984; 74: 1112-1116.
245. Stephenson ML, Krane SM, Amento ER Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of the procollagen mRNAs. FEBS Lett 1985; 180: 43-50.
246. Scharffetter K, Heckmann M, Hatamochi A, Mauch C, Stein B, Rietmüller G, Ziegler-Heitbrock H-WL, Krieg T. Synergistic effect of tumor necrosis factor-a and interferon-gamma on collagen synthesis of human skin fibroblasts in vitro. ExpCell Res 1989; 181: 409-419.
247. Mauch C, Adelmann-Grill B, Hatamochi A, Krieg T. Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen. FEBS Lett 1989; 250: 301-305.
248. Mauch C, Krieg T. Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis. Rheum Dis Clin N Am 1990; 16: 93-107.
249. Mauch C, Hatamochi A, Scharffetter K, Krieg T. Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel. Exp Cell Res 1988; 178: 493-503.
250. Kulozik M, Heckmann M, Mauch C, Scharffetter K,Krieg T. Cytokine regulation of collagen metabolism during wound healing in vitro and in vivo. In: Wound Healing, edited by Janssen H, Rooman R and Robertson JIS. Petersfield: Wrightson Biomedical Publishing Ltd, 1991: 33-39.
251. Jørgensen PH, Jensen KH, Andreassen IT. Mechanical strength in rat skin incisional wounds treated with fibrin sealant. J Surg Res 1987; 42: 237-241.
252. Forrest L. Current concepts in soft connective tissue wound healing. Br J Surg 1983; 70: 133-140.
253. Forrester JC. Mechanical, biochemical, and architectural features of surgical repair. Adv Biol Med Phys 1973; 14: 1-34.
254. Viljanto J, Kulonen E. Correlation of tensile strength and chemical composition in experimental granuloma. Acta Pathol Microbiol Scand A1962; 56: 120-126.
255. Reiser KM, Crouch EC, Chang K,Williamson JR. Lysyl oxidase-mediated crosslinking in granulation tissue collagen in two models of hyperglycemia. Biochim Biophys Acta 1991; 1097: 55-61.
256. Forrester JC, Zederfeldt BH, Hayes TL, Hunt TK. Tape-closed and sutured wounds: a comparison by tensiometry and scanning electron microscopy. Br J Surg 1970; 57: 729-737.
257. Forrester JC, Zederfeldt BH, Hunt TK.The tape-closed wound - a bioengineering analysis. J Surg Res 1969; 9: 537-542.
258. Taubenhaus M, Amromin GD. The effects of the hypohysis, thyroid, sex steroids, and the adrenal cortex upon granulation tissue. J Lab Clin Med 1950; 36: 7-18.
259. Taubenhaus M,Taylor B, Morton J. Hormonal interaction in the regulation of granulation tissue formation. Endocrinology 1952; 51: 183-191.
260. Steenfos H, Spencer M, Hunt TK. Insulin-like growth factor I has a major role in wound healing. Surg Forum 1989; 68-70.
261. Mueller RV,Tokunaga A, Hunt TK, Spencer EM. IGF-I stimulation of wound healing may act by increasing the number of wound macrophages. 2nd Int Symposium on Insulin-Like Growth Factors/Somatomedins 1991; 73. (Abstract)
262. Mueller RV, Spencer EM, Sommer A, Maack CA, Suh D,Hunt TK.The role of IGF-I and IGFBP-3 in wound Healing. In: Modern concepts of insulin-like growth fac-tors, edited by Spencer EM. New York: Elsevier Science Publishing, 1991: 185-192.
263. McDonald MJ, Bleichman M, Bunn HF, Noble RW Functional properties of the glycosylated minor components of human adult hemoglobin. J Biol Chem 1979; 254: 702-707.
264. Stebbins RB, Stoerk HC The local action of growth hormone upon granulation tissue formation. Am J Pathol 1954; 30: 615.
265. Gartner MH, Benson JD, Caldwell MD. Insulin-like growth factors I and II expression in the healing wound. J Surg Res 1992; 52: 389-394.
266. Steenfos HH, Jansson J-O. Gene expression of insulin-like growth factor-I and IGF-I receptor during wound healing in rats. Eur J Surg 1992; 158: 327-331.
267. Spencer EM, Skover G,Hunt TK. Somatomedins: do they play a pivotal role in wound healing? In: Growth factors and other aspects of wound healing: biological and clinical implications, edited by Barbul A. New York: Alan R. Liss, 1988: 103-116.
268. Herndon DN, Hawkins HK, NguyenTT, Pierre E, Cox R, Barrow RE. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 1995; 221: 649-659.
269. Jørgensen KD, Svendsen O, Greenough RJ, KallesenT, Goburdhun R, Skydsgaard K, Finch J, Dinesen B, Nilsson P. Biosynthetic human growth hormone: subchronic toxicity studies in rats and monkeys. Pharmacol Toxicol 1988; 62: 329-333.
270. Viljanto J. Biochemical basis of tensile strength in wound healing. Acta Chir Scand 1964; suppl 33: 1-101.
271. Kulonen E. Experimental granuloma as a tool in connective tissue research. In: The Methodology of Connective Tissue Research, edited by Hall DA. Oxford: Joynson-Bruwers Ltd, 1976: 29-36.
272. Holund B, Junker P, Garbarsch C, Christoffersen P, Lorenzen I. Formation of granulation tissue in subcutaneously implanted sponges in rats. Acta Pathol Microbiol Scand 1979; 87: 367-374.
273. Horslev-Petersen K, Pedersen LR, Bentsen KD, Brocks D, Garbarsch C, Kim KY, Hahn EG, Schuppan D, Lorenzen I. Collagen type IVand procollagen type III during granulation tissue formation: a serological, biochemical, immunohistochemical and morphometrical study on the viscose cellulose sponge rat model. Eur J Clin Invest 1988; 18: 352-359.
274. Woessner JF. Determination of hydroxyproline in connective tissues. In: The methodology of connective tissue research, edited by Hall DA. Oxford: Joynsson-Bruvvers, 1976: 227-233.
275. Stegeman H, Stalder KH. Determination of hydroxyproline. Clin Chim Acta 1967; 18: 267-273.
276. Hanson AN, Bentley JP. Quantitation of type I to type III collagen ratios in small samples of human tendon, blood vessels, and atherosclerotic plaque. Anal Biochem 1983; 130: 32-40.
277. Reiser KM, Last JA. Anomalous electrophoretic behavior of a cyanogen bromide peptide from type III collagen. Connect Tissue Res 1983; 12: 1-16.
278. Østergaard JR, Oxlund H. Collagen type III deficiency in patients with rupture of intracranial saccular aneurysms. J Neurosurg 1987; 67: 690-696.
279. Light ND, Bailey AI Polymeric C-terminal crosslinked material from type-I collagen. Biochem J 1980; 189: 111-124.
280. Light ND,Bailey AJ. Molecular structure and stabilization of the collagen fibre. In: Biology of Collagen, edited by Viidik A and Vuust J. London: Academic Press, 1980: 15-38.
281. Scott PG, Veis A. The cyanogen bromide peptides of bovine soluble and insoluble collagens. II. Tissue specific cross-linked peptides of insoluble skin and dentin collagen. Connect Tissue Res 1976; 4: 117-129.
282. Bailey AJ, Light ND. Intermolecular cross-linking in fibrotic collagen. In: Fibrosis, edited by Evered D and Whelan J. London: CIBA Foundation Symposium 114, Pitman, 1985: 80-96.
283. Flyvbjerg A, Ørskov H. Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: Relation to severity of diabetes. Acta Endocrinol (Copenh) 1990; 122: 374-378.
284. Ørskov H.Thomsen HG.Yde H.Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968; 219: 193-195.
285. Holly JMP, Amiel SA, Sandhu RR, Rees LH,Wass JAH. The role of growth hormone in diabetes mellitus. J Endocrinol 1988; 118: 353-364.
286. Møller N. The role of growth hormone in the regulation of human fuel metabolism. In: Growth hormone and insulin-like growth factor I, edited by Flyvbjerg A, Ørskov H and Alberti KOMM. John Wiley & Sons Ltd., 1993: 77-108.
287. Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 1987; 8: 115-131.
288. Groesbeck MD, Parlow AF. Highly improved precision of the hypophysectomized female rat body weight gain assay for growth hormone by increased frequency of injections, avoidance of antibody formation, and other simple modifications. Endocrinology 1987; 120: 2582-2590.
289. Fain JN, Kovacev VP, Scow RQ Effect of growth hormone and dexamethasone on lipolysis and metabolism in isolated fat cells of the rat. J Biol Chem 1965; 240: 3522-3529.
290. Gabrilove JL, Schwartz A, Churg J. Effect of hormones on the skin in endocrinologic disorders. J Clin Endocrinol Metab 1962; 22: 688-692.
291. Eyre DR. Collagen cross-linking amino acids. Methods Enzymol 1987; 14: 115-139.
292. Bernstein PH, Mechanic GL. A natural histidine-based imminium cross-link in collagen and its location. J Biol Chem 1980; 255: 10414-10422.
293. Epstein EH jr. Human skin collagen. Release by pepsin digestion and preponderance in fetal life. J Biol Chem 1974; 249: 3225-3231.
294. Chung E, Keele EM, Miller EJ. Isolation and characterization of the cyanogen bromide peptides from the α1(III) chain of human collagen. Biochemistry 1974; 13: 3459-3464.
295. Banfield WG. Effect of growth hormone on acetic acid-extractable collagen of hamster skin. Proc Soc Exp Biol Med 1958; 97: 309-312.
296. Bang C, Jørgensen PH, Andreassen TT, Oxlund H. Increased collagen deposition and decreased mechanical strength in skin from old rats treated with growth hormone. In manuscript.
297. MacGorman LR, Rizza RA, Gerich JE. Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab 1981; 53: 556-559.
298. Sasaki T, Ramamurthy NS, Golub LM. Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: a quantitative autoradiographic study. Calcif Tissue Int 1992; 50: 411-419.
299. Brændgaard H, Jørgensen PH, Andreassen TT. The effect of 2,5-hexanedione on newly formed collagen in granulation tissue. Pharmacol Toxicol 1987; 61: 63-65.
300. Bak B. Fracture healing and growth hormone. A biomechanical study in the rat. Dan Med Bull 1993; 40: 519-536.
301. Tavis MJ,Thornton JW, Harney JH, Danet RT, Woodroof EA, Bartlett RH. Mechanism of skin graft adherence: collagen, elastin, and fibrin interactions. Surg Forum 1977; 28: 522-525.
302. Klein L, Rudolph R. 3H-Collagen turnover in skin grafts. Surg Gynecol Obstet 1972; 135: 49-57.
303. Zika JM, Rudolph R, Klein L. Autoradiographic distribution of collagen loss in skin grafts. Anat Rec 1973; 177: 377-392.
304. Rudolph R, Klein L. Isotopic measurement of collagen turnover in skin grafts. Surg Forum 1971; 22: 489-491.
305. Hinshaw JR, Miller ER. Histology of healing split-thickness, full-thickness autogenous skin grafts and donor sites. Arch Surg 1965; 91: 658-670.
306. Fogdestam I. Abiomechanical study of healing rat skin incisions after delayed primary closure. Surg Gynecol Obstet 1981; 153: 191-199.
307. Delany HM, Demetriou AA,Teh E, Levenson SM. Effect of early postoperative nutritional support on skin wound and colon anastomosis healing. J Parenter Enteral Nutr 1990; 14: 357-361.
308. Saikku LA. The effect of somatotropin and thyrotropin on granulation tissue. Ann Med Exp Biol Fen 1956; 34 (suppl 10):1-30.
309. Mikkonen L, Lampiaho K, Kulonen E. Effect of thyroid hormones, somatotrophin, insulin and corticosteroids both in vivo and in vitro. Acta Endocrinol 1966; 51: 23-31.
310. Kowalewski K,Yong S. Effect of growth hormone, an anabolic steroid, and cortisone upon various fractions of skin and bone hydroxyproline in mice. Can J Phyisol Pharmacol 1968; 46: 591-594.
311. Spain DM, Molomut N. Failure of somatotrophic hormone (STH) to counteract cortisone action on wounds in mice. Proc Soc Exp Biol Med 1953; 83: 326.
312. Selye H. Influence of somatotrophic hormone and cortisol upon the development of tissue necrosis. J Endocrinol 1954; 10: 347-350.
313. Bunn HF, Gabbay KH, Gallop PM.The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978; 200: 21-27.
314. Christensen H, Oxlund H, Laurberg S. Growth hormone increases the bursting strength of colonic anastomoses. An experimental study in the rat. Int J Color Dis 1990; 5: 130-134.
315. Christensen H, Flyvbjerg A. Dose-dependent stimulatory effect of human growth hormone on the strength and collagen deposition of colonic anastomoses in the rat. Acta Endocrinol (Copenh) 1992; 126: 438-443.
316. Christensen H, Oxlund H. Growth hormone increases the collagen deposition rate and breaking strength of left colon anastomoses in rats. Surgery 1994; 116: 550-556.
317. Jørgensen PH, Andreassen TT. The Influence of biosynthetic human growth hormone on biomechanical properties and collagen formation in granulation tis-sue. Horm Metab Res 1988; 20: 490-493.
318. Garrel DR, Gaudreau P, Zhang L, Reeves I, Brazeau P. Chronic administration of growth hormone-releasing factor increases wound strength and collagen maturation in granulation tissue. J Surg Res 1991; 51: 297-302.
319. Steenfos HH, Jansson J-O. Growth hormone stimulates granulation tissue formation and insulin-like growth factor-I gene expression in wound chambers in the rat. J Endocrinol 1992; 132: 293-298.
320. Rasmussen LH, Garbarsch C, Schuppan D, Moe D, Horslev-Pedersen K, Gottrup F, Steenfos H. Influence of human growth hormone on granulation tissue formation, collagen deposition, and the aminoterminal propeptide of collagen type III in wound chambers in rats. Wound Rep Reg 1994; 2: 31-36.
321. Rasmussen LH, Garbarsch C, Schuppan D, Moe D, Horslev-Pedersen K, Gottrup F, Steenfos H. Dose response profiles of human growth hormone in subcutaneous wound chambers in rats. Eur J Surg 1995; 161: 157-162.
322. Jørgensen JOL, Flyvbjerg A, Lauritzen T, Ørskov H, Christiansen JS. Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patients. Acta Endocrinol (Copenh) 1988; 118: 154-158.
323. Granot I, Halevy O, Hurwitz S, Pines M. Growth hormone and insulin-like growth factor I regulate collagen gene expression and extracellular collagen in cultures of avian skin fibroblasts. Mol Cell Endocrinol 1991; 80: 1-9.
324. Canalis EM, Hintz RL, Dietrich JW, Maina DM, Raisz LG. Effect of somatomedin and growth hormone on bone collagen synthesis in vitro. Metabolism 1977; 26: 1079-1087.
325. Canalis E. The hormonal and local regulation of bone formation. Endocr Rev 1983; 4: 62-77.
326. Grygiencza W, Orlowski T, Przystasz T, Badowski A. Effect of cyclophosphamide, trenimon, somatotropin and nerobolil of healing of experimental cutaneo-muscular wound. Acta Med Pol 1983; 24: 25-41.
327. Belcher HJCR, Ellis H. Somatropin and wound heal-ing after injury. J Clin Endocrinol Metab 1990; 70: 939-943.
328. Hollander DM, Devereux DF, Marafino BJ, Hoppe H. Increased wound breaking strength in rats following treatment with synthetic human growth hormone. Surg Forum 1984; 35: 612-614.
329. Pessa ME, Bland KI, Sitren HS, Miller GJ, Copeland III E,M.. Improved wound healing in tumor-bearing rats treated with perioperative synthetic human growth hormone. Surg Forum 1986; 36: 6-8.
330. ZaizenY, Ford EG, Costin G, Atkinson JB.The effect of perioperative exogenous growth hormone on wound bursting strength in normal and malnourished rats. J Pediatr Surg 1990; 25: 70-74.
331. ZaizenY, Ford EG, Costin G, Atkinson JB. Stimulation of wound bursting strength during protein malnutrition. J Surg Res 1990; 49: 333-336.
332. Takano K, Mouri N, Sakurai H, Muto S, Koshizuka K, TadaY Effect of growth hormone on wound healing in protein-malnourished rats treated with corticosteroids. J Pediatr Surg 1994; 29: 790-793.
333. Andreassen TT, Oxlund H.The influence of experimental diabetes and insulin treatments on the biomechanical properties of rat skin incisional wounds. Acta Chir Scand 1987; 153: 405-409.
334. Gottrup F, Andreassen TT. Healing of incisional wounds in stomach and duodenum: the influence of experimental diabetes. J Surg Res 1981; 31: 61-68.
335. Oxlund H, Fogdestam I, Viidik A. The influence of cortisol on wound healing of the skin and distant connective tissue response. Surg Gynecol Obstet 1979; 148: 876-880.
336. Oxlund H. Changes in connective tissues during corticotrophin and corticosteroid treatment. Dan Med Bull 1984; 31: 187-206.
337. Atkinson JB, Kosi M, Srikanth MS, Takano K, Costin G. Growth hormone reverses impaired wound healing in protein-malnourished rats treated with corticosteroids. J Pediatr Surg 1992; 27: 1026-1028.
338. Harrison LE, Port JL, Hochwald S, Blumberg D, Burt M. Perioperative growth hormone improves wound healing and immunologic function in rats receiving adriamycin. J Surg Res 1995; 58: 646-650.
339. Ferguson MK. The effect of antineoplastic agents on wound healing. Surg Gynecol Obstet 1982; 154: 421-429.
340. Devereux D, Kent H, Brennan MF. Time dependent effects of adriamycin and X-ray therapy on wound healing in the rat. Cancer 1980; 45: 2805-2810.
341. Devereux DF, Thibault L, Boretos J, Brennan MF. Cancer 1979; 43: 932-978.
342. Kelley KW. Growth hormone, lymphocytes and macrophages. Biochem Pharmacol 1989; 38: 705-713.
343. Weigent DA, Blalock JE. The production of growth hormone by subpopulations of rat mononuclear leukocytes. Cell Immunol 1991; 135: 55-65.
344. Wiedermann CJ, Niedermühlbichler M, Geissler D, Beimpold H, Braunsteiner H. Priming of normal human neutrophils by recombinant human growth hormone. Br J Haematol 1991; 78: 19-22.
345. Rasmussen LH, Karlsmark T, Avnstorp C, Peters K, Jørgensen M, Jensen LT. Topical human growth hormone treatment of chronic leg ulcers. Phlebology 1991; 6: 23-30.
346. Rasmussen LH, Jensen LT, Avnstorp C, Karlsmark T, Peters K, Horslev-Petersen K. Collagen types I and III propeptides as markers of healing in chronic leg ulcers. A noninvasive method for the determination of procollagen propeptides in wound fluid-influence of growth hormone. Ann Surg 1992; 216: 684-691.
347. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990; 212: 424-429.
348. Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN. Recombinant human growth hormone accelerates wound healing in children with large cutaneous wounds. Ann Surg 1994; 220: 19-24.
349. Belcher HJCR, Mercer D, Judkins KC, Shalaby S,Wise S, Marks V, Tanner NS. Biosynthetic human growth hormone in burned patients: a pilot study. Burns 1989; 15: 99-107.
350. Gore DC, Honeycutt D, Jahoor F,Wolfe RR, Herndon DN. Effect of exogenous growth hormone on wholebody and isolated-limb protein kinetics in burned patients. Arch Surg 1991; 126: 38-43.
351. Fleming RYD, Rutan RL, Jahoor F, Barrow RE,Wolfe RR, Herndon DN. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma 1992; 32: 698-702.
352. Ramirez AT, Soroff HS, Schwartz MS, Mooty J, Pearson E, Raben MS. Experimental wound healing in man. SurgGynecol Obstet 1969; 128: 283-293.
353. Welsh KM, Lamit M, Morhenn VB. The effect of recombinant human growth hormone on wound healing in normal individuals. J Dermatol Surg Oncol 1991; 17: 942-945.
354. Terry LC, Willoughby JO, Brazeau P, Martin JB. Antiserum to somatostatin prevents stress-induced inhibition of growth hormone secretion in the rat. Science 1976; 192: 565-567.
355. Schalch DS,Reichlin S. Stress and growth hormone release. In: Growth hormone. Proceedings of the first international symposium. Milan, Italy, September 11-13,1967, edited by Pecile A and Müller EE. Amsterdam: Excerpta Medica Foundation, 1968: 211-225.
356. Brown GM, Martin JB. Corticosterone, Prolactin, and growth hormone responses to handling and new environment in the rat. Psychosom Med 1974; 36: 241-247.
357. Arimura A, Smith WD, Schally AV. Blockade of the stress-induced decrease in blood GH by anti-somatostatin serum in rats. Endocrinology 1976; 98: 540-543.
358. Liberti JP, Miller MS. Stimulation of human fibroblast protein, ribonucleic acid, and deoxyribonucleic acid synthesis by bovine growth hormone fragments. Endocrinology 1978; 102: 1757-1760.
359. Lindahl A, Isgaard J, Nilsson A, Isaksson OGR Growth hormone potentiates colony formation of epiphyseal chondrocytes in suspension culture. Endocrinology 1986; 118: 1843-1848.
360. Edwards CKIII, Ghiasuddin SM, Schepper JM, Yunger LM, Kelley KW. A newly defined property of somatotropin: Priming of macrophages for production of Superoxide anion. Science 1988; 239: 769-771.
361. Jørgensen PH, Pedersen CB, Andreassen TT. Mechanical properties of skin transplants and co-existing incisional wounds compared with ordinary incisional wounds. Proceedings from International Surgical Week, Stockholm, Sweden 1991; 282. (Abstract)